DermWire | Newest Articles http://practicaldermatology.com/dermwire/ Newest Articles en-us Tue, 18 Dec 2018 18:25:08 GMT Tue, 18 Dec 2018 18:25:08 GMT DermWire Rio Professor Develops Sunscreen for Hair http://practicaldermatology.com/dermwire/view.asp?url=rio-professor-develops-sunscreen-for-hair A Rio professor and her team of students have developed the first national product capable of protecting hair from sun radiation. According to Ana Percebom, of the Scientific Technical Center of University PUC in Rio, none of the products currently sold have substances that actually block sun radiation. The research, presented at a recent congress in Brazil, is the result of student Amanda de Azevedo Stavale’s Master’s thesis in Chemistry. Its innovation lies in the class of nanop… Tue, 18 Dec 2018 04:00:00 GMT New Study Seeks to Improve Skin Cancer Prevention in Young Adults Via a New Website http://practicaldermatology.com/dermwire/view.asp?url=new-study-seeks-to-improve-skin-cancer-prevention-in-young-adults-via-a-new-website Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study to evaluate the reach and effectiveness of an online program targeted at skin cancer prevention in young adults. Investigators are refining an existing website to help young adults reduce this risk. The new-and-improved website can be accessed at www.UV4me.org. Some 1,500 young adults will take part in the study. Participants will complete several online questionnaires a… Tue, 18 Dec 2018 04:00:00 GMT RealSelf Forms Strategic Medical Advisory Council http://practicaldermatology.com/dermwire/view.asp?url=realself-forms-strategic-medical-advisory-council RealSelf, Inc. has formed a Strategic Medical Advisory Council with three operating boards. The RealSelf Strategic Advisory Council is made up of the Business Advisory Board, the Medical Review Advisory Board and the Industry Advisory Board, all of which are comprised of board-certified doctors and surgeons. The formation of the council follows the appointment of the first RealSelf Chief Medical Officer last summer. "As a fast-moving technology company in the rapidly-changing aesthetics … Mon, 17 Dec 2018 04:00:00 GMT Hologic’s Cynosure Division Launches TempSure Surgical RF Technology in North America http://practicaldermatology.com/dermwire/view.asp?url=hologics-cynosure-division-launches-tempsure-surgical-rf-technology-in-north-america Hologic, Inc.’s Cynosure division is launching the U.S. Food and Drug Administration (FDA)-cleared TempSure Surgical RF technology in North America. This is a new offering for the TempSure radiofrequency (RF) platform that provides clinicians the ability to perform both surgical and non-surgical aesthetic procedures across a variety of specialties, on a single device. Cynosure also has returned TempSure Vitalia hand pieces and probes to the market and will continue to market its MonaLi… Thu, 13 Dec 2018 04:00:00 GMT New Study Investigates Prurigo Nodularis Treatments http://practicaldermatology.com/dermwire/view.asp?url=new-study-investigates-prurigo-nodularis-treatments Emerging treatments such as neurokinin-1 receptor antagonists show the most promise for prurigo nodularis, according to a review in JAMA Dermatology. Neurokinin-1 receptor is a target of substance P, a mediator of itch and a probable pathogenic agent of prurigo nodularis. Adam Friedman, MD, professor of dermatology at the George Washington University School of Medicine and Health Sciences and his team looked at 35 studies with differences in factors such as the number of subjects and the d… Thu, 13 Dec 2018 04:00:00 GMT AD, Suicidal Thoughts and Attempts Linked http://practicaldermatology.com/dermwire/view.asp?url=ad-suicidal-thoughts-and-attempts-linked Patients with eczema may be more likely to have suicidal thoughts and attempts compared to their counterparts without eczema, according to a new study in JAMA Dermatology. Researchers evaluated the association between eczema and suicidal thoughts and attempts by analyzing the combined results of 15 studies including 310,000 patients with eczema and 4.4 million people without eczema. They found that patients with atopic dermatitis had a 44 percent increased odds of suicidal ideation and a 36 p… Wed, 12 Dec 2018 04:00:00 GMT EWG VERIFIED Goes Mainstream with Herbal Essences Shampoos http://practicaldermatology.com/dermwire/view.asp?url=ewg-verified-goes-mainstream-with-herbal-essences-shampoos The EWG VERIFIED program is launching nationwide in stores with Procter & Gamble’s two new Herbal Essences shampoos. The two Herbal Essences shampoos were reformulated to meet the Environmental Working Group's (EWG) rigorous criteria for transparency and health and now have the EWG VERIFIED mark. The Herbal Essences shampoos will hit store shelves in January 2019 and be available for sale at Walmart, Target, CVS, Kroger, Dollar General, Meijer, Publix, Walgreens and Amazon. … Wed, 12 Dec 2018 04:00:00 GMT Almirall and X-Chem Team Up to Develop Oral Compounds for Dermatological Diseases http://practicaldermatology.com/dermwire/view.asp?url=almirall-and-x-chem-team-up-to-develop-oral-compounds-for-dermatological-diseases Almirall, S.A. signed a collaborative research and license agreement with the X-Chem, Inc. for the development of oral compounds for patients suffering from dermatological diseases, a strategic area for Almirall. X-Chem, Inc. is a privately held biotechnology company focused on applying its industry-leading DNA-encoded library (DEX) drug discovery engine to the generation of novel small molecule therapeutics. This collaboration will enrich Almirall’s R&D pipeline with the development … Wed, 12 Dec 2018 04:00:00 GMT SENTE Launches Collaborations with Galderma, The HydraFacial Company http://practicaldermatology.com/dermwire/view.asp?url=sente-launches-collaborations-with-galderma-the-hydrafacial-company New strategic collaborations are intended to broaden the reach of SENTÉ and further expand their disruptive professional grade skin care product portfolio, the company says. Both collaborations will offer consumers the opportunity to experience SENTÉ's patented Sulfated Glycosaminoglycan (SuGAG) analog technology clinically proven to deliver rapid skin rejuvenation. The new joint marketing collaboration with Galderma in the US allows SENTÉ's products to be offered… Tue, 11 Dec 2018 04:00:00 GMT Case Study: Whole Body Cryotherapy Causes Cold Burn Injury http://practicaldermatology.com/dermwire/view.asp?url=case-study-whole-body-cryotherapy-causes-cold-burn-injury A 71-year-old man experienced a blistering cold burn after receiving a whole-body cryotherapy treatment for back pain and arthritis, according to a case study published online in JAAD Case Reports. Whole-body cryotherapy involves encasing the entire body, apart from the head, in an extremely cold chamber for a short duration. The chamber is cooled by liquid nitrogen, and the patient’s injury likely resulted from a malfunctioning nozzle that sprayed the substance directly onto his back, … Tue, 11 Dec 2018 04:00:00 GMT New Acoustic Shockwave Technology May Speed Laser Tattoo Removal http://practicaldermatology.com/dermwire/view.asp?url=new-acoustic-shockwave-technology-may-speed-laser-tattoo-removal Soliton, Inc. is introducing new acoustic shockwave technology for quicker laser tattoo removal. What’s more, the new device also shows potential in aesthetics market for cellulite and fat removal. The patented Rapid Acoustic Pulse (RAP) device uses acoustic shockwaves that accelerated the speed of tattoo removal when used with lasers, delivering results in as little as two to three treatments versus the 10 to 12 average with the current standard of care lasers alone, the company st… Tue, 11 Dec 2018 04:00:00 GMT Dermatologists Need More Info About Cannabinoids http://practicaldermatology.com/dermwire/view.asp?url=dermatologists-need-more-info-about-cannabinoids Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new survey in Journal of Drugs in Dermatology. However, many are concerned about the associated societal stigmas,which may be limiting their pursuit of these active agents as potential treatments. The survey included 531 participants who answered 19 multiple choice questions on demographics as well as perspectives on and knowledge of cannabinoids use in dermatology. With t… Tue, 11 Dec 2018 04:00:00 GMT Asana Biosciences Gets Fast Track Designation from FDA for Dual JAK/SYK Inhibitor for AD http://practicaldermatology.com/dermwire/view.asp?url=asana-biosciences-gets-fast-track-designation-from-fda-for-dual-jaksyk-inhibitor-for-ad The FDA has granted Fast Track designation to Asana BioSciences’ investigational oral Janus Kinase (JAK) and Spleen Tyrosine Kinase (SYK) dual inhibitor ASN002 for the treatment of moderate-to-severe atopic dermatitis. “We are pleased that the FDA has granted Fast Track designation to ASN002. This designation recognizes the importance of accelerating the development of new medicines for the treatment of challenging dermatological/inflammatory diseases that have a major impact on … Mon, 10 Dec 2018 04:00:00 GMT Naked Eye, Smart Phone Apps May Miss Melanomas http://practicaldermatology.com/dermwire/view.asp?url=naked-eye-smart-phone-apps-may-miss-melanomas The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, according to a new review published in The Cochrane Library as part of a Special Collection of Cochrane Systematic Reviews bringing together a large body of research on the accuracy of tests used to diagnose skin cancer. The suite of 11 reviews was led by Jac Dinnes, PhD, MSc, MA, PGDip, a senior researcher at the University of Birmingham in the UK and supported by the Cochran… Fri, 7 Dec 2018 04:00:00 GMT New Xeomin "Later Haters" Campaign Urges Women to “X” Out Judgment http://practicaldermatology.com/dermwire/view.asp?url=new-xeomin-later-haters-campaign-aims-to-x-out-judgment Merz Americas is launching a new advertising campaign for Xeomin (incobotulinumtoxinA) called “Later Haters,” which urges women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling guilty about their self-care routines. The new advertising campaign will be featured across multiple channels nationwide and further amplified in select markets. “Later Haters” is geared toward a new audience -- “The Reclaimers.… Thu, 6 Dec 2018 04:00:00 GMT Low 3% Keloid Recurrence Found in Multicenter Case Series of Patients Treated with SRT http://practicaldermatology.com/dermwire/view.asp?url=low-3-keloid-recurrence-found-in-multicenter-case-series-of-patients-treated-with-srt Sensus Healthcare, Inc., a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), shared positive results of a multicenter case series of patients treated with the SRT-100 following complete surgical keloidectomy. Of the 297 keloidectomy patients treated post-operatively with superficial radiation, there were nine cases of observed clinical keloid recurrences, or a recurrence rate … Thu, 6 Dec 2018 04:00:00 GMT Phase 3 Data Positive for Revance's RT002 http://practicaldermatology.com/dermwire/view.asp?url=phase-3-data-positive-for-revances-rt002 Long-acting neuromodulator daxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate to severe glabellar lines in the SAKURA 3 Phase 3 open-label, long-term safety study. Completion of this study paves the way for Revance Therapeutics, Inc. to submit a Biologics License Application (BLA) with the FDA, which is on-track for the first half of 2019. “The results of this trial are exceptional since they demonstrate that RT002 has consistently and … Tue, 4 Dec 2018 04:00:00 GMT New PsA Guidelines from National Psoriasis and Rheumatology Orgs Recommend Treat-to-Target Approach http://practicaldermatology.com/dermwire/view.asp?url=new-psa-guidelines-from-national-psoriasis-and-rheumatology-orgs-recommend-treat-to-target-approach Newly released psoriatic Arthritis (PsA) treatment guidelines from the National Psoriasis Foundation (NPF) and the American College of Rheumatology (ACR) are calling for a treat-to-target approach for all patients with active PsA. What’s more, the guidelines conditionally recommend use of tumor necrosis factor inhibitor (TNFi) biologics as a first-line therapy option in patients with active PsA and offer a strong recommendation for smoking avoidance/cessation. “Treat-to-target … Tue, 4 Dec 2018 04:00:00 GMT Sinclair Pharma Announces Leadership Changes http://practicaldermatology.com/dermwire/view.asp?url=sinclair-pharma-announces-leadership-changes Sinclair Pharma Limited reported that effective at the end of the year, Doug Abel has resigned his position as Head of North America and President of Silhouette Lift, Inc., to lead a new aesthetic venture and has licensed the US sales and marketing rights to the Refine Support System from Sinclair. The company has also appointed Amber Edwards to the positions of President, Silhouette Lift, Inc., and Head of North America for Sinclair Pharma. In her new role, Ms. Edwards will lead commercial o… Mon, 3 Dec 2018 04:00:00 GMT Crown Laboratories Acquires Select Healthcare Brands from GlaxoSmithKline http://practicaldermatology.com/dermwire/view.asp?url=crown-laboratories-acquires-select-healthcare-brands-from-glaxosmithkline Crown Laboratories, Inc. has acquired North American distribution rights of five OTC consumer brands from GlaxoSmithKline (GSK). The acquired portfolio includes: PanOxyl® daily acne wash, Sarna® anti-itch lotion, Zeasorb® anti-fungal and prevention product, Desenex® anti-fungal powder for athlete’s foot, and Mineral Ice® pain-relieving gel. The brands all have a strong heritage and lengthy history in the market. PanOxyl, Sarna, and Zeasorb are three former Stiefel La… Fri, 30 Nov 2018 04:00:00 GMT Cosmetic Surgery Forum Kicks Off in Las Vegas http://practicaldermatology.com/dermwire/view.asp?url=cosmetic-surgery-forum-kicks-off-in-las-vegas With new and returning faculty, controversial and timely topics, and an all new venue, Cosmetic Surgery Forum (CSF) kicks off its 10th year at the chic Cosmopolitan Hotel. The meeting features 50 sessions and a robust exhibit floor. This year’s Cosmetic Surgery Forum will not shy away from controversy, assures founder Joel Schlessinger, MD. For example, members of the 2018 faculty will take on the growing use of lasers and other energy-based devices for female rejuvenation. “… Thu, 29 Nov 2018 04:00:00 GMT Hair Loss Breakthrough: Team Regrows Hair on Wounded Skin http://practicaldermatology.com/dermwire/view.asp?url=hair-loss-breakthrough-team-regrows-hair-on-wounded-skin By stirring crosstalk among skin cells that form the roots of hair, researchers have regrown hair strands on damaged skin. The findings, which appear in the November issue of the journal Nature Communications, better explain why hair does not normally grow on wounded skin, and may help in the search for better drugs to restore hair growth, say the study’s authors. The study examined the effect of distinct signaling pathways in damaged skin of laboratory mice. Experiments focused on f… Wed, 28 Nov 2018 04:00:00 GMT Study: Lipid that Aids Normal Skin Turnover May Help Psoriasis http://practicaldermatology.com/dermwire/view.asp?url=study-lipid-that-aids-normal-skin-turnover-may-help-psoriasis A lipid that helps keep skin cell turnover on track may help restore healthy turnover in psoriasis, investigators say. Topical application of the lipid phosphatidylglycerol, or PG, on a mouse model of psoriasis reduced inflammation as well as characteristic, raised skin lesions, they report in the Journal of Investigative Dermatology. They had already shown that PG has a role in both regulating the function of the major cell type in our skin called keratinocytes and suppressing skin inflammat… Wed, 28 Nov 2018 04:00:00 GMT Encore Dermatology Announces Phase 2 Safety Data for Impoyz http://practicaldermatology.com/dermwire/view.asp?url=encore-dermatology-announces-phase-2-safety-data-for-impoyz A Phase 2, open-label study published in SKIN The Journal of Cutaneous Medicine, found that subjects treated with Impoyz (clobetasol propionate) Cream, 0.025% showed significantly lower mean post-treatment clobetasol propionate plasma concentrations versus the subjects treated with Temovate (clobetasol propionate) Cream, 0.05% (56.3 vs 152.5 pg/mL). Both treatment groups evidenced similar improvements in global psoriasis severity as measured by improvements in the Investigator’s Global Ass… Wed, 28 Nov 2018 04:00:00 GMT CeraVe Launches Hyaluronic Acid Serum, Line of Products for Diabetic Skin http://practicaldermatology.com/dermwire/view.asp?url=cerave-launches-hyaluronic-acid-serum-line-of-products-for-diabetic-skin L'Oréal’s CeraVe is rolling out a Hydrating Hyaluronic Acid Serum and a Diabetics' Dry Skin Relief line, which includes a Moisturizing Cream, Hand and Foot Cream and a Cleansing Wash. Hitting shelves in late 2018, the Diabetics' Dry Skin Relief line was developed to address the specific skincare needs of people with diabetes and help reduce their risk of skin complications. "As the number of diabetes sufferers continues to rise, it was important to us that we … Tue, 27 Nov 2018 04:00:00 GMT